GST council announces significant reduction in GST on cancer medicines
New Delhi: The GST Council, at its 54th meeting, announced the big cuts in GST on cancer medicines. It is slashed from 12 per cent to 5 per cent on life-saving drugs like Trastuzumab Deruxtecan, Osimertinib, and Durvalumab. This comes in the wake of making life-saving cancer treatment options more affordable to patients. It is